Search

Your search keyword '"Santos-Garcia D"' showing total 6 results
Start Over Author "Santos-Garcia D" Publisher revista de neurologia
6 results on '"Santos-Garcia D"'

2. [Gastroparesis and other gastrointestinal symptoms in Parkinson's disease].

Author

Santos-Garcia D, de Deus T, Tejera-Perez C, Exposito-Ruiz I, Suarez-Castro E, Carpintero P, and Macias-Arribi M

Subjects
Antiparkinson Agents adverse effects, Antiparkinson Agents therapeutic use, Bruxism etiology, Bruxism physiopathology, Comorbidity, Deglutition Disorders etiology, Deglutition Disorders physiopathology, Digestive System Diseases physiopathology, Gastrointestinal Hormones metabolism, Gastroparesis etiology, Gastroparesis physiopathology, Humans, Malnutrition etiology, Parkinson Disease drug therapy, Parkinson Disease physiopathology, Sialorrhea etiology, Sialorrhea physiopathology, Symptom Assessment, Vagus Nerve physiopathology, Weight Loss, Digestive System Diseases etiology, Enteric Nervous System physiopathology, Parkinson Disease complications
Abstract

Different gastrointestinal symptoms, such as excessive salivation, deterioration and other disorders affecting the teeth, dysphagia, gastroparesis, gastroesophageal reflux, constipation, difficult defecation or loss of weight are frequent events in all the stages of the development of Parkinson's disease and affect at least a third of the patients. These symptoms reflect the dysfunction of the enteric nervous system, and the stomach is one of the organs where alpha-synuclein is first deposited. Other factors, such as the dysfunction of structures in the central nervous system like the dorsal motor nucleus of the vagal nerve, hormonal factors or secondary effects deriving from the consumption of antiparkinsonian drugs, are involved in its origin. The present article offers a detailed review of the epidemiological, pathophysiological, clinical and therapeutic management aspects of the different gastrointestinal symptoms in Parkinson's disease.

Published
2015

3. [Anton's syndrome due to occipital necrosis after methanol poisoning].

Author

Santos-Garcia D, Lopez-Dequidt IA, Exposito-Ruiz I, Fraga-Bau A, and de la Fuente-Fernandez R

Subjects
Acidosis chemically induced, Adult, Blindness, Cortical diagnostic imaging, Combined Modality Therapy, Humans, Magnetic Resonance Imaging, Male, Necrosis, Neuroimaging, Occipital Lobe diagnostic imaging, Occipital Lobe pathology, Psychomotor Agitation etiology, Tomography, X-Ray Computed, Visual Cortex diagnostic imaging, Visual Cortex drug effects, Visual Cortex pathology, Blindness, Cortical chemically induced, Methanol poisoning, Occipital Lobe drug effects
Published
2015

4. [Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease].

Author

Santos-Garcia D, de Deus T, Lopez-Pazos E, Macias-Arribi M, Llaneza-Gonzalez MA, Echarri-Piudo A, Carpintero P, and de la Fuente-Fernandez R

Subjects
Antiparkinson Agents adverse effects, Antiparkinson Agents therapeutic use, Carbidopa adverse effects, Carbidopa therapeutic use, Double-Blind Method, Drug Therapy, Combination, Duodenum, Gastrointestinal Diseases chemically induced, Granuloma etiology, Granuloma therapy, Humans, Infusion Pumps adverse effects, Infusions, Parenteral, Levodopa adverse effects, Levodopa therapeutic use, Multicenter Studies as Topic, Observational Studies as Topic, Pain etiology, Peritonitis etiology, Postoperative Complications etiology, Prospective Studies, Randomized Controlled Trials as Topic, Retrospective Studies, Surgical Stomas adverse effects, Antiparkinson Agents administration & dosage, Carbidopa administration & dosage, Gastrostomy adverse effects, Levodopa administration & dosage, Parkinson Disease drug therapy, Postoperative Complications therapy
Abstract

Continuous infusion of intraduodenal levodopa/carbidopa is an effective treatment that improves the motor complications and the quality of life of patients in the advanced stages of Parkinson's disease. However, it is not free of complications. These may present in the post-operative period following surgery (gastrostomy) or in the long-term during the follow-up period and can be related with the medication (levodopa/carbidopa), the stoma, the gastrostomy or the device (pump, enteral tube, parts of the FREKA system). The aim of this review is to report on the management of the complications that can be observed in patients with advanced Parkinson's disease treated with continuous infusion of intraduodenal levodopa/carbidopa.

Published
2014

5. [Magnetic resonance imaging and epileptic status].

Author

Santos-Garcia D, Vazquez-Herrero F, Rodriguez-Osorio X, and Prieto JM

Subjects
Aged, Fatal Outcome, Female, Humans, Magnetic Resonance Imaging, Status Epilepticus pathology, Status Epilepticus physiopathology
Published
2006

6. [SUNCT syndrome secondary to megadolichobasilar anomaly].

Author

Santos-Garcia D, Prieto JM, Blanco-Gonzalez M, Iglesias-Gomez S, Rodriguez-Constenla I, and Lema M

Subjects
Aged, Basilar Artery pathology, Diagnosis, Differential, Headache Disorders pathology, Headache Disorders physiopathology, Humans, Male, Syndrome, Basilar Artery abnormalities, Headache Disorders etiology, Vertebrobasilar Insufficiency complications, Vertebrobasilar Insufficiency pathology
Published
2005

Catalog

Books, media, physical & digital resources
See catalog results